[
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71(3):209.10.3322/caac.2166033538338
]Search in Google Scholar
[
2. Baliu-Piqué M, Pandiella A, Ocana A. Breast cancer heterogeneity and response to novel therapeutics. Cancers (Basel) 2020; 12(11):3271.10.3390/cancers12113271769430333167363
]Search in Google Scholar
[
3. Aggarwal S, Verma SS, Aggarwal S, Gupta SC. Drug repurposing for breast cancer therapy: Old weapon for new battle. Semin Cancer Biol 2021; 68:8-20.10.1016/j.semcancer.2019.09.012712877231550502
]Search in Google Scholar
[
4. Polyak K. Heterogeneity in breast cancer. J Clin Invest 2011; 121(10):3786-8.10.1172/JCI60534319548921965334
]Search in Google Scholar
[
5. Senapati S, Mahanta AK, Kumar S, Maiti P. Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct Target Ther 2018; 3:7.10.1038/s41392-017-0004-3585457829560283
]Search in Google Scholar
[
6. Mansoori B, Mohammadi A, Davudian S, Shirjang S, Baradaran B. The different mechanisms of cancer drug resistance: A Brief Review. Adv Pharm Bull 2017; 7(3):339-48.10.15171/apb.2017.041565105429071215
]Search in Google Scholar
[
7. Xie M, Liu D, Yang Y. Anti-cancer peptides: classification, mechanism of action, reconstruction and modification. Open Biol 2020; 10(7):200004.10.1098/rsob.200004757455332692959
]Search in Google Scholar
[
8. Tornesello AL, Borrelli A, Buonaguro L, Buonaguro FM, Tornesello ML. Antimicrobial peptides as anticancer agents: functional properties and biological activities. Molecules 2020; 25(12):2850.10.3390/molecules25122850735614732575664
]Search in Google Scholar
[
9. Pantic JM, Jovanovic IP, Radosavljevic GD, Arsenijevic NN, Conlon JM, Lukic ML. The potential of frog skinderived peptides for development into therapeuticallyvaluable immunomodulatory agents. Molecules 2017; 22(12):2071.10.3390/molecules22122071615003329236056
]Search in Google Scholar
[
10. Burdukiewicz M, Sidorczuk K, Rafacz D, Pietluch F, Bąkała M, Słowik J et al. CancerGram: an effective classifier for differentiating anticancer from antimicrobial peptides. Pharmaceutics 2020; 12(11):1045.10.3390/pharmaceutics12111045769264133142753
]Search in Google Scholar
[
11. Ju X, Fan D, Kong L, Yang Q, Zhu Y, Zhang S et al. Antimicrobial peptide brevivin-1RL1 from frog skin secretion induces apoptosis and necrosis of tumor cells. Molecules 2021; 26(7):2059.10.3390/molecules26072059803834733916789
]Search in Google Scholar
[
12. Mangoni ML, Casciaro B. Development of antimicrobial peptides from Amphibians. Antibiotics (Basel) 2020; 9(11):772.10.3390/antibiotics9110772769278633158031
]Search in Google Scholar
[
13. Conlon JM, Mechkarska M, Abdel-Wahab YH, Flatt PR. Peptides from frog skin with potential for development into agents for Type 2 diabetes therapy. Peptides 2018; 100:275-81.10.1016/j.peptides.2017.09.00128887047
]Search in Google Scholar
[
14. Chiangjong W, Chutipongtanate S, Hongeng S. Anticancer peptide: physicochemical property, functional aspect and trend in clinical application (Review). Int J Oncol 2020; 57(3):678-96.10.3892/ijo.2020.5099738484532705178
]Search in Google Scholar
[
15. Baxter AA, Lay FT, Poon IKH, Kvansakul M, Hulett MD. Tumor cell membrane-targeting cationic antimicrobial peptides: novel insights into mechanisms of action and therapeutic prospects. Cell Mol Life Sci 2017; 74(20):3809-25.10.1007/s00018-017-2604-z28770291
]Search in Google Scholar
[
16. Perrin BS Jr, Pastor RW. Simulations of membrane-disrupting peptides I: Alamethicin pore stability and spontaneous insertion. Biophysical Journal 2016; 111(6):1248-57.10.1016/j.bpj.2016.08.014503436527653483
]Search in Google Scholar
[
17. Kuo HM, Tseng CC, Chen NF, Tai MH, Hung HC, Feng CW et al. MSP-4, an antimicrobial peptide, induces apoptosis via activation of extrinsic Fas/FasLand intrinsic mitochondria-mediated pathways in one osteosarcoma Ccll line Mar Drugs 2018; 16(1):8
]Search in Google Scholar
[
18. Beesoo R, Neergheen-Bhujun V, Bhagooli R, Bahorun T. Apoptosis inducing lead compounds isolated from marine organisms of potential relevance in cancer treatment. Mutat Res 2014; 768:84-97.10.1016/j.mrfmmm.2014.03.00524685981
]Search in Google Scholar
[
19. Wu SP, Huang TC, Lin CC, Hui CF, Lin CH, Chen JY. Pardaxin, a fish antimicrobial peptide, exhibits antitumor activity toward murine fibrosarcoma in vitro and in vivo. Mar Drugs 2012; 10(8):1852-72.
]Search in Google Scholar
[
20. Li X, Shen B, Chen Q, Zhang X, Ye Y, Wang F et al. Antitumor effects of cecropin B-LHRH’ on drug-resistant ovarian and endometrial cancer cells. BMC Cancer 2016; 16:251.10.1186/s12885-016-2287-0480903627021903
]Search in Google Scholar
[
21. Hilchie AL, Hoskin DW, Power Coombs MR. Anticancer Activities of Natural and Synthetic Peptides. Adv Exp Med Biol 2019; 1117:131-47.10.1007/978-981-13-3588-4_930980357
]Search in Google Scholar
[
22. Wang YK, He HL, Wang GF, Wu H, Zhou BC, Chen XL et al. Oyster (Crassostrea gigas) hydrolysates produced on a plant scale have antitumor activity and immunostimulating effects in BALB/c mice. Mar Drugs 2010; 8(2):255-68.10.3390/md8020255285283720390104
]Search in Google Scholar
[
23. Li D, Wang W, Shi HS, Fu YJ, Chen X, Chen XC et al. Gene therapy with beta-defensin 2 induces antitumor immunity and enhances local antitumor effects. Hum Gene Ther 2014; 25(1):63-72.10.1089/hum.2013.16124134464
]Search in Google Scholar
[
24. Economopoulou M, Bdeir K, Cines DB, Fogt F, Bdeir Y, Lubkowski J et al. Inhibition of pathologic retinal neovascularization by alpha-defensins. Blood 2005; 106(12):3831-8.10.1182/blood-2005-03-0889189509816123222
]Search in Google Scholar
[
25. Chavakis T, Cines DB, Rhee JS, Liang OD, Schubert U, Hammes HP et al. Regulation of neovascularization by human neutrophil peptides (alpha-defensins): a link between inflammation and angiogenesis. FASEB J 2004; 18(11):1306-8.10.1096/fj.03-1009fje15208269
]Search in Google Scholar
[
26. Xu N, Wang YS, Pan WB, Xiao B, Wen YJ, Chen XC et al. Human alpha-defensin-1 inhibits growth of human lung adenocarcinoma xenograft in nude mice. Mol Cancer Ther 2008; 7(6):1588-97.10.1158/1535-7163.MCT-08-001018566229
]Search in Google Scholar
[
27. Jin, G.; Weinberg, A. Human antimicrobial peptides and cancer. Semin Cell Dev Biol 2019; 88:156-162.10.1016/j.semcdb.2018.04.00629694838
]Search in Google Scholar
[
28. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003; 3(9):710-20.10.1038/nri118012949495
]Search in Google Scholar
[
29. Sun CQ, Arnold RS, Hsieh CL, Dorin JR, Lian F, Li Z et al. Discovery and mechanisms of host defense to oncogenesis: targeting the β-defensin-1 peptide as a natural tumor inhibitor. Cancer Biol Ther 2019; 20(6):774-86.10.1080/15384047.2018.1564564660599230900935
]Search in Google Scholar
[
30. Cutone A, Rosa L, Ianiro G, Lepanto MS, Bonaccorsi di Patti MC, Valenti P et al. Lactoferrin’s anti-cancer properties: safety, selectivity, and wide range of action. Biomolecules 2020; 10(3):456.10.3390/biom10030456717531132183434
]Search in Google Scholar
[
31. Zhang Y, Nicolau A, Lima CF, Rodrigues LR. Bovine lactoferrin induces cell cycle arrest and inhibits mTOR signaling in breast cancer cells. Nutr Cancer 2014; 66(8):1371-85.10.1080/01635581.2014.95626025356800
]Search in Google Scholar
[
32. Barragán-Cárdenas A, Urrea-Pelayo M, Niño-Ramírez VA, Umaña-Pérez A, Paul Vernot J, Parra-Giraldo CM et al. Selective cytotoxic effect against the MDA-MB-468 breast cancer cell line of the antibacterial palindromic peptide derived from bovine lactoferricin. RSC Adv 2020; 10:17593-601.10.1039/D0RA02688C905360835515633
]Search in Google Scholar
[
33. Insuasty-Cepeda DS, Barragán-Cárdenas AC, Ochoa- Zarzosa A, López-Meza JE, Fierro-Medina R, García- Castañeda JE et al. Peptides derived from (RRWQWRMKKLG)2-K-Ahx induce selective cellular death in breast cancer cell lines through apoptotic pathway. Int J Mol Sci 2020; 21(12):4550.10.3390/ijms21124550735295232604743
]Search in Google Scholar
[
34. Vargas Casanova Y, Rodríguez Guerra JA, Umaña Pérez YA, Leal Castro AL, Almanzar Reina G, García Castañeda JE et al. Antibacterial synthetic peptides derived from bovine lactoferricin exhibit cytotoxic effect against MDA-MB-468 and MDA-MB-231 breast cancer cell lines. Molecules 2017; 22(10):1641.10.3390/molecules22101641615143728961215
]Search in Google Scholar
[
35. Chen X, Zou X, Qi G, Tang Y, Guo Y, Si J et al. Roles and mechanisms of human cathelicidin LL-37 in cancer. Cell Physiol Biochem 2018; 47(3):1060-73.10.1159/00049018329843147
]Search in Google Scholar
[
36. Chen X, Ji S, Si J, Zhang X, Wang X, Guo Y et al. Human cathelicidin antimicrobial peptide suppresses proliferation, migration and invasion of oral carcinoma HSC-3 cells via a novel mechanism involving caspase-3 mediated apoptosis. Mol Med Rep 2020; 22(6):5243-50.10.3892/mmr.2020.11629764699233174023
]Search in Google Scholar
[
37. Bruns H, Büttner M, Fabri M, Mougiakakos D, Bittenbring JT, Hoffmann M et al. Vitamin D-dependent induction of cathelicidin in human macrophages results in cytotoxicity against high-grade B cell lymphoma. Sci Transl Med 2015; 7:282ra47.10.1126/scitranslmed.aaa323025855493
]Search in Google Scholar
[
38. Gambade A, Zreika S, Guéguinou M, Chourpa I, Fromont G, Bouchet AM et al. Activation of TRPV2 and BKCa channels by the LL-37 enantiomers stimulates calcium entry and migration of cancer cells. Oncotarget 2016; 7(17):23785-800.10.18632/oncotarget.8122502966326993604
]Search in Google Scholar
[
39. Chen J, Shin VY, Ho JC, Siu MT, Cheuk IW, Kwong A. Functional implications of cathelicidin antimicrobial protein in breast cancer and tumor-associated macrophage microenvironment. Biomolecules 2020; 10(5):688.10.3390/biom10050688727777932365569
]Search in Google Scholar
[
40. Conlon JM, Mechkarska M, Lukic ML, Flatt PR. Potential therapeutic applications of multifunctional host-defense peptides from frog skin as anti-cancer, anti-viral, immunomodulatory, and anti-diabetic agents. Peptides 2014; 57:67-77.10.1016/j.peptides.2014.04.01924793775
]Search in Google Scholar
[
41. Wang C, Li HB, Li S, Tian LL, Shang DJ. Antitumor effects and cell selectivity of temporin-1CEa, an antimicrobial peptide from the skin secretions of the Chinese brown frog (Rana chensinensis). Biochimie 2012; 94(2):434-41.10.1016/j.biochi.2011.08.01121871946
]Search in Google Scholar
[
42. Wang C, Tian LL, Li S, Li HB, Zhou Y, Wang H et al. Rapid cytotoxicity of antimicrobial peptide temporin- 1CEa in breast cancer cells through membrane destruction and intracellular calcium mechanism. PLoS One 2013; 8(4):e60462.10.1371/journal.pone.0060462361842523577112
]Search in Google Scholar
[
43. Wang C, Dong S, Zhang L, Zhao Y, Huang L, Gong X et al. Cell surface binding, uptaking and anticancer activity of L-K6, a lysine/leucine-rich peptide, on human breast cancer MCF-7 cells. Sci Rep 2017; 7(1):8293.10.1038/s41598-017-08963-2555790128811617
]Search in Google Scholar
[
44. Wang C, Huang L, Li R, Wang Y, Wu X, Shang D. Synergistic therapy of doxorubicin with cationic anticancer peptide L-K6 reverses multidrug resistance in cancer cells in vitro via P-glycoprotein inhibition. bioRxiv 2021; 429308.10.1101/2021.02.02.429308
]Search in Google Scholar
[
45. Ghavami S, Asoodeh A, Klonisch T, Halayko AJ, Kadkhoda K, Kroczak TJ et al. Brevinin-2R(1) semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway. J Cell Mol Med 2008; 12(3):1005-22.10.1111/j.1582-4934.2008.00129.x440114418494941
]Search in Google Scholar
[
46. Attoub S, Arafat H, Mechkarska M, Conlon JM. Antitumor activities of the host-defense peptide hymenochirin- 1B. Regul Pept 2013; 187:51-6.10.1016/j.regpep.2013.10.00624185042
]Search in Google Scholar
[
47. Zhang Y, Sun C, Xiao G, Gu Y. Host defense peptide Hymenochirin-1B induces lung cancer cell apoptosis and cell cycle arrest through the mitochondrial pathway. Biochem Biophys Res Commun 2019; 512(2):269-75.10.1016/j.bbrc.2019.03.02930885438
]Search in Google Scholar
[
48. Serra I, Scorciapino MA, Manzo G, Casu M, Rinaldi AC, Attoub S et al. Conformational analysis and cytotoxic activities of the frog skin host-defense peptide, hymenochirin- 1Pa. Peptides 2014; 61:114-21.10.1016/j.peptides.2014.08.01725241629
]Search in Google Scholar
[
49. Pantic J, Guilhaudis L, Musale V, Attoub S, Lukic ML, Mechkarska M et al. Immunomodulatory, insulinotropic, and cytotoxic activities of phylloseptins and plasticin- TR from the Trinidanian leaf frog Phyllomedusa trinitatis. J Pept Sci 2019; 25(4):e3153.10.1002/psc.315330734396
]Search in Google Scholar
[
50. Conlon JM, Mechkarska M, Prajeep M, Arafat K, Zaric M, Lukic ML et al. Transformation of the naturally occurring frog skin peptide, alyteserin-2a into a potent, non-toxic anti-cancer agent. Amino Acids 2013; 44(2):715-23.10.1007/s00726-012-1395-722965637
]Search in Google Scholar
[
51. Mechkarska M, Attoub S, Sulaiman S, Pantic J, Lukic ML, Conlon JM. Anti-cancer, immunoregulatory, and antimicrobial activities of the frog skin host-defense peptides pseudhymenochirin-1Pb and pseudhymenochirin- 2Pa. Regul Pept 2014; 194-195:69-76.10.1016/j.regpep.2014.11.00125447194
]Search in Google Scholar
[
52. Pantic JM, Jovanovic IP, Radosavljevic GD, Gajovic NM, Arsenijevic NN, Conlon JM et al. The frog skin host-defense peptide frenatin 2.1S enhances recruitment, activation and tumoricidal capacity of NK cells. Peptides 2017; 93:44-50.10.1016/j.peptides.2017.05.00628526557
]Search in Google Scholar
[
53. Hilchie AL, Sharon AJ, Haney EF, Hoskin DW, Bally MB, Franco OL et al. Mastoparan is a membranolytic anti-cancer peptide that works synergistically with gemcitabine in a mouse model of mammary carcinoma. Biochim Biophys Acta 2016; 1858(12):3195-204.10.1016/j.bbamem.2016.09.021509702927693190
]Search in Google Scholar
[
54. Jeong YJ, Choi Y, Shin JM, Cho HJ, Kang JH, Park KK et al.. Melittin suppresses EGF-induced cell motility and invasion by inhibiting PI3K/Akt/mTOR signaling pathway in breast cancer cells. Food Chem Toxicol 2014; 68:218-25.10.1016/j.fct.2014.03.02224675423
]Search in Google Scholar
[
55. Yang Y, Zhang H, Wanyan Y, Liu K, Lv T, Li M et al. Effect of hydrophobicity on the anticancer activity of fatty-acyl-conjugated CM4 in breast cancer cells. ACS Omega 2020; 5(34):21513-23.10.1021/acsomega.0c02093746938432905373
]Search in Google Scholar
[
56. Marqus S, Pirogova E, Piva TJ. Evaluation of the use of therapeutic peptides for cancer treatment. J Biomed Sci 2017; 24(1):21.10.1186/s12929-017-0328-x535982728320393
]Search in Google Scholar
[
57. Hilchie AL, Doucette CD, Pinto DM, Patrzykat A, Douglas S, Hoskin DW. Pleurocidin-family cationic antimicrobial peptides are cytolytic for breast carcinoma cells and prevent growth of tumor xenografts. Breast Cancer Res 2011; 13(5):R102.10.1186/bcr3043326221522023734
]Search in Google Scholar
[
58. Vernen F, Harvey PJ, Dias SA, Veiga AS, Huang YH, Craik DJ et al. Characterization of tachyplesin peptides and their cyclized analogues to improve antimicrobial and anticancer properties. Int J Mol Sci 2019; 20(17):4184.10.3390/ijms20174184674708731455019
]Search in Google Scholar
[
59. Kuzmin DV, Emelianova AA, Kalashnikova MB, Panteleev PV, Balandin SV, Serebrovskaya EO et al. Comparative in vitro study on cytotoxicity of recombinant β- hairpin peptides. Chem Biol Drug Des 2018; 91(1):294-303.10.1111/cbdd.1308128815904
]Search in Google Scholar
[
60. Shaala LA, Youssef DTA, Ibrahim SRM, Mohamed GA. Callyptide A, a new cytotoxic peptide from the Red Sea marine sponge Callyspongia species. Nat Prod Res 2016; 30(24):2783-90.10.1080/14786419.2016.115557726946937
]Search in Google Scholar
[
61. E-Kobon T, Thongararm P, Roytrakul S, Meesuk L, Chumnanpuen P. Prediction of anticancer peptides against MCF-7 breast cancer cells from the peptidomes of Achatina fulica mucus fractions. Comput Struct Biotechnol J 2015; 14:49-57.10.1016/j.csbj.2015.11.005470661126862373
]Search in Google Scholar
[
62. He S, Mao X, Zhang T, Guo X, Ge Y, Ma C et al. Separation and nanoencapsulation of antitumor peptides from Chinese three-striped box turtle (Cuora trifasciata). J Microencapsul 2016; 33(4):344-54.10.1080/02652048.2016.119490427292913
]Search in Google Scholar
[
63. Figueira TN, Oliveira FD, Almeida I, Mello ÉO, Gomes VM, Castanho MARB et al. Challenging metastatic breast cancer with the natural defensin PvD1. Nanoscale 2017; 9(43):16887-99.10.1039/C7NR05872A
]Search in Google Scholar
[
64. Pandurangi SR, Karwa A, Sagaram SU, Shah D. Medicago sativa defensin 1 (MsDef1), a natural tumor targeted sensitizer for improving chemotherapy: Translation from Anti-Fungal Agent to Potential Anti-Cancer. Agentio Rxiv 2021; 43112.10.1101/2021.02.13.431112
]Search in Google Scholar
[
65. Fang XY, Chen W, Fan JT, Song R, Wang L, Gu YH et al. Plant cyclopeptide RA-V kills human breast cancer cells by inducing mitochondria-mediated apoptosis through blocking PDK1-AKT interaction. Toxicology and Applied Pharmacology 2013; 267(1):95-103.10.1016/j.taap.2012.12.01023274515
]Search in Google Scholar
[
66. Brown KL, Hancock RE. Cationic host defense (antimicrobial) peptides. Curr Opin Immunol 2006; 18:24–30.10.1016/j.coi.2005.11.00416337365
]Search in Google Scholar
[
67. Melero I, Gaudernack G, Gerritsen W, Huber C, Parmiani G, Scholl S et al. Therapeutic vaccines for cancer: an overview of clinical trials. Nat Rev Clin Oncol 2014; 11:509–24.10.1038/nrclinonc.2014.11125001465
]Search in Google Scholar
[
68. Tian Y, Hu Q, Zhang R, Zhou B, Xie D, Wang Y et al. Rational design of innate defense regulator peptides as tumor vaccine adjuvants. NPJ Vaccines 2021; 6(1):75.10.1038/s41541-021-00334-3813801334016984
]Search in Google Scholar